Literature DB >> 33982353

Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders.

Margareta Holmström1,2, Elsa Olsson1, Jan Astermark3,4, Malin Axelsson4, Anna Olsson5, Linda Myrin Westesson5, Aletta Falk6, Johan Szamosi6, Karin Sennfält6.   

Abstract

Entities:  

Keywords:  extended half-life; factor consumption; haemophilia A; joint health; rFVIIIFc

Year:  2021        PMID： 33982353     DOI： 10.1111/hae.14316

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

Review 1.  Efmoroctocog Alfa: A Review in Haemophilia A.

Authors:  James E Frampton
Journal:  Drugs       Date:  2021-11-07       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.